EGRX
Thrivent Financial for Lutherans’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,319
| Closed | -$293K | – | 2555 |
|
|
2023
Q1 | $293K | Sell |
10,319
-362
| -3% | -$10.3K | ﹤0.01% | 2296 |
|
|
2022
Q4 | $312K | Sell |
10,681
-305
| -3% | -$8.91K | ﹤0.01% | 2248 |
|
|
2022
Q3 | $290K | Buy |
10,986
+7
| +0.1% | +$185 | ﹤0.01% | 2238 |
|
|
2022
Q2 | $488K | Buy |
10,979
+1,728
| +19% | +$76.8K | ﹤0.01% | 2110 |
|
|
2022
Q1 | $458K | Buy |
9,251
+3
| +0% | +$149 | ﹤0.01% | 2213 |
|
|
2021
Q4 | $471K | Sell |
9,248
-68
| -0.7% | -$3.46K | ﹤0.01% | 2209 |
|
|
2021
Q3 | $520K | Sell |
9,316
-222
| -2% | -$12.4K | ﹤0.01% | 2166 |
|
|
2021
Q2 | $408K | Buy |
9,538
+12
| +0.1% | +$513 | ﹤0.01% | 2246 |
|
|
2021
Q1 | $398K | Sell |
9,526
-73
| -0.8% | -$3.05K | ﹤0.01% | 2305 |
|
|
2020
Q4 | $447K | Sell |
9,599
-443
| -4% | -$20.6K | ﹤0.01% | 2176 |
|
|
2020
Q3 | $427K | Buy |
10,042
+1,563
| +18% | +$66.5K | ﹤0.01% | 2048 |
|
|
2020
Q2 | $407K | Hold |
8,479
| – | – | ﹤0.01% | 1993 |
|
|
2020
Q1 | $390K | Buy |
8,479
+424
| +5% | +$19.5K | ﹤0.01% | 1854 |
|
|
2019
Q4 | $484K | Buy |
8,055
+19
| +0.2% | +$1.14K | ﹤0.01% | 1906 |
|
|
2019
Q3 | $455K | Sell |
8,036
-48
| -0.6% | -$2.72K | ﹤0.01% | 1878 |
|
|
2019
Q2 | $450K | Sell |
8,084
-314
| -4% | -$17.5K | ﹤0.01% | 1882 |
|
|
2019
Q1 | $424K | Buy |
8,398
+673
| +9% | +$34K | ﹤0.01% | 1874 |
|
|
2018
Q4 | $311K | Buy |
7,725
+169
| +2% | +$6.8K | ﹤0.01% | 1795 |
|
|
2018
Q3 | $524K | Buy |
7,556
+1,847
| +32% | +$128K | ﹤0.01% | 1664 |
|
|
2018
Q2 | $432K | Buy |
5,709
+362
| +7% | +$27.4K | ﹤0.01% | 1754 |
|
|
2018
Q1 | $282K | Buy |
5,347
+32
| +0.6% | +$1.69K | ﹤0.01% | 1881 |
|
|
2017
Q4 | $284K | Buy |
5,315
+105
| +2% | +$5.61K | ﹤0.01% | 1908 |
|
|
2017
Q3 | $311K | Sell |
5,210
-823,610
| -99% | -$49.2M | ﹤0.01% | 1775 |
|
|
2017
Q2 | $65.4M | Buy |
828,820
+824,220
| +17,918% | +$65M | 0.27% | 95 |
|
|
2017
Q1 | $382K | Buy |
4,600
+400
| +10% | +$33.2K | ﹤0.01% | 1660 |
|
|
2016
Q4 | $333K | Buy |
4,200
+60
| +1% | +$4.76K | ﹤0.01% | 1675 |
|
|
2016
Q3 | $290K | Buy |
+4,140
| New | +$290K | ﹤0.01% | 1714 |
|